Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2015
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504953/
http://dx.doi.org/10.1182/blood-2015-06-649848
_version_ 1782381526855450624
collection PubMed
description
format Online
Article
Text
id pubmed-4504953
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-45049532015-07-28 Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152. Blood Errata American Society of Hematology 2015-07-16 /pmc/articles/PMC4504953/ http://dx.doi.org/10.1182/blood-2015-06-649848 Text en © 2015 by The American Society of Hematology
spellingShingle Errata
Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title_full Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title_fullStr Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title_full_unstemmed Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title_short Schinke C, Giricz O, Li W, et al. IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells. Blood. 2015;125(20):3144-3152.
title_sort schinke c, giricz o, li w, et al. il8-cxcr2 pathway inhibition as a therapeutic strategy against mds and aml stem cells. blood. 2015;125(20):3144-3152.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504953/
http://dx.doi.org/10.1182/blood-2015-06-649848

Ejemplares similares